About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

UniQuest, AstraZeneca Collaborate on Drug Discovery

Font : A-A+

 UniQuest, AstraZeneca Collaborate on Drug Discovery

The pharmaceutical company AstraZeneca comes together with UniQuest to form an "open innovation" and paves the way for the discovery of new therapeutic drugs. Researchers from UniQuest, the research commercialization company of The University of Queensland, will now have access to high-quality compounds from AstraZeneca. The researchers will investigate human mechanisms of disease and explore various novel target therapies and medical innovations. AstraZeneca, in turn, will have the opportunity to deeply engage with UniQuest researchers and their projects.

UniQuest's drive to expand the aim of The University of Queensland with regard to drug discovery and development will be reinforced with this collaboration with AstraZeneca. Dr. Dean Moss, CEO of UniQuest, stated that the initiative has been another step towards the new era of medical discovery via open innovation and public-private collaboration. He added that UniQuest was delighted to be partnering with AstraZeneca in the exciting approach towards the development of new treatments for patients and advancement of medical science in Australia.

Advertisement

Dr. Moss said that the collaboration would help foster medical innovation by bringing together complementary skills and the combined efforts of the academic innovators can accelerate the investigation of therapeutic treatments.

UniQuest, an Australian research commercialization company specializes in global technology transfer. UniQuest facilitates access of world class expertise, intellectual property and facilities at The University of Queensland, Australia, for all business sectors. The University of Queensland is among the top 100 universities worldwide and is a leading research and teaching institution.
Advertisement

Successful proposals to investigate human mechanisms of disease and drug discovery and development can be submitted by the UniQuest researchers. The research would be funded jointly by UniQuest and AstraZeneca.

Dr. Ajay Gautam, AstraZeneca's executive director of Scientific Partnering and Alliances for Asia Pacific, said that this collaborative drug discovery will focus on AstraZeneca's core therapeutic areas including oncology, metabolic, respiratory, cardiovascular, autoimmune, inflammation, infection and neuroscience diseases.

Dr. Gautam also said that giving their compounds and expertise to globally leading academic research institutions such as UniQuest, they would be opening doors to unexplored areas of pre-clinical and clinical research to help find the next generation of medical innovations.

AstraZeneca is one of the biopharmaceutical businesses which is innovation-driven with focus on the discovery, development and commercialization of prescription medicines in various areas of medical innovations. Its open source drug discovery program incorporates opening the drug discovery projects to external contributors resulting in significant increase in its research capacity. Open source drug discovery also offers potential for developing new and inexpensive drugs to combat diseases.

Fragment based drug discovery, another area of research in AstraZeneca, is based on identifying small chemical fragments that bind weakly to the biological target. These chemicals are grown together to combine them to produce a drug that then binds strongly to make the drug more effective.

Both UniQuest and AstraZeneca bring complimentary skills to foster medical innovation. The combination of The University of Queensland's thought-leadership and experiences in investigating medical hypotheses and AstraZeneca's proven track record of drug discovery and development can work wonders in understanding therapeutic treatments based on human mechanisms of disease and target therapies.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Signature Drug Toxicity Top Ten Selling Drugs Drugs Banned in India 

Recommended Reading
Therapeutic Classification Drugs
Therapeutic Classification Drugs...
Body Therapy Techniques
Body firming, sculpting and inch loss have become an integral part of any weight loss procedure. ......
Daily Water Intake
Calculate how much glasses of water you need to drink each day to avoid dehydration using this ......
Clinical Trials
Clinical trials are experiments that yield useful information to clinicians if a particular treatmen...
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Clinical Trials - The Past and The Future
Many of the drugs that are used today have been discovered by chance or often by mere serendipity...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)